Raymond James Financial Services Advisors’s VanEck Biotech ETF BBH Stock Holding History

Raymond James Financial Services Advisors’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$3.2M	Sell	18,025 -589	-3%	-$105K	﹤0.01%	1473
2024 Q2	$3.13M	Sell	18,614 -566	-3%	-$92.6K	﹤0.01%	1421
2024 Q1	$3.19M	Buy	19,180 +51	+0.3%	+$8.45K	﹤0.01%	1390
2023 Q4	$3.16M	Buy	19,129 +4,909	+35%	+$756K	0.01%	1323
2023 Q3	$2.21M	Buy	14,220 +521	+4%	+$83.2K	﹤0.01%	1449
2023 Q2	$2.14M	Buy	13,699 +2,044	+18%	+$327K	﹤0.01%	1474
2023 Q1	$1.89M	Buy	11,655 +59	+0.5%	+$9.55K	﹤0.01%	1524
2022 Q4	$1.85M	Sell	11,596 -58	-0.5%	-$9.19K	﹤0.01%	1480
2022 Q3	$1.64M	Buy	11,654 +1,190	+11%	+$180K	﹤0.01%	1532
2022 Q2	$1.53M	Sell	10,464 -121	-1%	-$18K	﹤0.01%	1597
2022 Q1	$1.72M	Buy	10,585 +4,295	+68%	+$696K	﹤0.01%	1590
2021 Q4	$1.19M	Buy	6,290 +171	+3%	+$33K	﹤0.01%	1861
2021 Q3	$1.24M	Buy	6,119 +74	+1%	+$15.5K	﹤0.01%	1812
2021 Q2	$1.22M	Sell	6,045 -99	-2%	-$18.4K	﹤0.01%	1812
2021 Q1	$1.08M	Buy	6,144 +134	+2%	+$24.2K	﹤0.01%	1797
2020 Q4	$1.02M	Sell	6,010 -415	-6%	-$68.4K	﹤0.01%	1687
2020 Q3	$1.04M	Buy	6,425 +431	+7%	+$70.1K	﹤0.01%	1530
2020 Q2	$977K	Buy	5,994 +1,745	+41%	+$265K	﹤0.01%	1499
2020 Q1	$544K	Buy	4,249 +331	+8%	+$44.6K	﹤0.01%	1494
2019 Q4	$546K	Buy	+3,918	New	+$515K	﹤0.01%	1924
2018 Q4	–	Sell	-8,864	Closed	-$1.21M	–	2583
2018 Q3	$1.21M	Buy	8,864 +1,205	+16%	+$157K	0.01%	1352
2018 Q2	$919K	Buy	7,659 +1,217	+19%	+$143K	﹤0.01%	1470
2018 Q1	$776K	Sell	6,442 -4,493	-41%	-$564K	﹤0.01%	1470
2017 Q4	$1.36M	Buy	10,935 +6,643	+155%	+$848K	0.01%	1108
2017 Q3	$576K	Buy	4,292 +383	+10%	+$49.9K	﹤0.01%	1631
2017 Q2	$491K	Buy	3,909 +643	+20%	+$77.5K	﹤0.01%	1684
2017 Q1	$389K	Buy	3,266 +199	+6%	+$23.3K	﹤0.01%	1724
2016 Q4	$330K	Sell	3,067 -451	-13%	-$49.1K	﹤0.01%	1759
2016 Q3	$405K	Buy	3,518 +635	+22%	+$72.4K	﹤0.01%	1611
2016 Q2	$295K	Buy	2,883 +264	+10%	+$28.2K	﹤0.01%	1730
2016 Q1	$272K	Buy	+2,619	New	+$273K	﹤0.01%	1606

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Raymond James Financial Services Advisors's BBH Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its VanEck Biotech ETF (BBH) stake by 3.2% in Q3 2024, selling an estimated $105K and leaving 18,025 shares worth $3.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1473.

Raymond James Financial Services Advisors first reported a position in BBH in Q1 2016 and has held it in 31 quarters since. 115 funds tracked by Wall St. Rank hold BBH as of Q3 2024.

Raymond James Financial Services Advisors held 18,025 shares of VanEck Biotech ETF worth $3.2M as of Q3 2024.
Raymond James Financial Services Advisors sold 589 VanEck Biotech ETF shares in Q3 2024, an estimated $105K.
VanEck Biotech ETF made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1473 holding.
Raymond James Financial Services Advisors first reported a position in VanEck Biotech ETF in Q1 2016 and has held it in 31 quarters since.
115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.